Surveillance of Viral Hemorrhagic Fever Viruses in Lassa Fever Suspects in Ondo State, Nigeria
暂无分享,去创建一个
S. Omilabu | O. Faye | Martin Faye | Fehintola A. Ige | R. Audu | O. Salu | Oumar Ndiaye | A. James | A. Okwuraiwe | J. Shaibu | O. Amoo | F. Ige
[1] J. Tibenderana,et al. The impact of malaria coinfection on Ebola virus disease outcomes: A systematic review and meta-analysis , 2021, PloS one.
[2] B. Salako,et al. Immunological screening of Lassa Virus among Health workers and Contacts of patients of Lassa fever in Ondo State. , 2021, Immunobiology.
[3] B. Salako,et al. Monitoring of Lassa virus infection in suspected and confirmed cases in Ondo State, Nigeria , 2020, The Pan African medical journal.
[4] S. Talebi,et al. Evaluation of Human Anti IgG Polyclonal Antibody Production Conjugated with Peroxidase in Egg Yolk , 2019, Iranian journal of public health.
[5] C. Ihekweazu,et al. The Nigeria Centre for Disease Control , 2018, BMJ Global Health.
[6] A. Maxmen. Deadly Lassa-fever outbreak tests Nigeria's revamped health agency , 2018, Nature.
[7] Felix von Stetten,et al. Rapid Molecular Assays for the Detection of Yellow Fever Virus in Low-Resource Settings , 2014, PLoS neglected tropical diseases.
[8] J. Klingström,et al. Development and evaluation of a broad reacting SYBR-green based quantitative real-time PCR for the detection of different hantaviruses. , 2013, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.
[9] B. Baradaran,et al. Mass-Production and Characterization of Anti-CD20 Monoclonal Antibody in Peritoneum of Balb/c Mice. , 2013, Advanced pharmaceutical bulletin.
[10] R. Hewson,et al. Evidence of arbovirus co-infection in suspected febrile malaria and typhoid patients in Nigeria. , 2013, Journal of infection in developing countries.
[11] E. Wherry,et al. Redefining Chronic Viral Infection , 2009, Cell.
[12] S. Krudsood,et al. Malaria diagnosis: a brief review. , 2009, The Korean journal of parasitology.
[13] M. Guzmán,et al. Kinetics of antibodies in sera, saliva, and urine samples from adult patients with primary or secondary dengue 3 virus infections. , 2007, International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases.
[14] O. Ogbu,et al. Lassa fever in West African sub-region: an overview. , 2007, Journal of vector borne diseases.
[15] D. Cleri,et al. Viral Hemorrhagic Fevers: Current Status of Endemic Disease and Strategies for Control , 2006, Infectious Disease Clinics of North America.
[16] Stuart T. Nichol,et al. Rapid Diagnosis of Ebola Hemorrhagic Fever by Reverse Transcription-PCR in an Outbreak Setting and Assessment of Patient Viral Load as a Predictor of Outcome , 2004, Journal of Virology.
[17] M. Guzmán,et al. MAC-ELISA and ELISA inhibition methods for detection of antibodies after yellow fever vaccination. , 2003, Journal of virological methods.
[18] Christian Drosten,et al. Rapid Detection and Quantification of RNA of Ebola and Marburg Viruses, Lassa Virus, Crimean-Congo Hemorrhagic Fever Virus, Rift Valley Fever Virus, Dengue Virus, and Yellow Fever Virus by Real-Time Reverse Transcription-PCR , 2002, Journal of Clinical Microbiology.
[19] R. G. Darling,et al. USAMRIID's Medical Management of Biological Casualties Handbook, Fourth Edition , 2001 .
[20] J. McCormick,et al. Viral hemorrhagic fever antibodies in Nigerian populations. , 1988, The American journal of tropical medicine and hygiene.
[21] J. Frame,et al. Lassa fever, a new virus disease of man from West Africa. I. Clinical description and pathological findings. , 1970, The American journal of tropical medicine and hygiene.